Document is current
Any future updates will be listed below
-
Authors
Wissmüller, Max
Dohr, Johannes
Adler, Joana
Ochs, Laurin
Tichelbäcker, Tobias
Hohmann, Christopher
Baldus, Stephan
Rosenkranz, Stephan
- License Information
-
More Information
Article History
Accepted: 27 April 2023
First Online: 8 June 2023
Declarations
:
: J. Dohr, L. Ochs, T. Tichelbäcker and S. Baldus declare that they have no competing interests. M. Wissmüller has received remunerations for lectures from Janssen; J. Adler has received lecture fees from Janssen and MSD; C. Hohmann has received lecture/consultancy fees from Actelion, Bayer, MSD, and Pfizer; S. Rosenkranz has received fees for lectures and/or consultations from Abbott, Acceleron, Actelion, Aerovate, Altavant, AOP Orphan, AstraZeneca, Bayer, Boehringer-Ingelheim, Edwards, Ferrer, Gossamer, Janssen, MSD, United Therapeutics, and Vifor; his institution has received research grants from Actelion, AstraZeneca, Bayer, and Janssen.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
